You searched for "pharmaceuticals"
Experiences of patients and their families and the impact of Leber hereditary optic neuropathy
The authors present a qualitative study which aimed to explore the impact of Leber hereditary optic neuropathy (LHON) from diagnosis to present day on both patients and their families. Individuals with LHON and their families were purposively sampled from four...EU: is it time to leave and embrace the world?
Should the United Kingdom remain a member of the European Union (EU) or leave? It’s a big decision involving some complex issues, and there’s no doubt the EU will continue to change. Ipsos MORI’s monthly EU voting intention poll published...Rayner announces acquisition of Sophi
Rayner, a global leader in products for cataract surgery headquartered in Worthing, UK, announced today (17 January 2024) that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.Ophthalmic Drugs Conference 2020
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on 23-24 November 2020, in London.New team member for Topcon Surgical
Topcon Great Britain Medical has announced a new addition to the Topcon Surgical team.It’s not all about ARED - Time for a pragmatic approach to nutrition for eye health?
Advances in treatment for retinal diseases involving neovascularisation have undoubtedly changed the future of eye care across the UK for the better, but also created great challenges for service delivery in ophthalmology, particularly within the NHS. Some statistics are starting...
Risk of intraocular haemorrhage with new oral anticoagulants
The authors conducted a study to assess the risk of intraocular haemorrhage with warfarin dabigatran, rivaroxaban, apixaban. All reported cases of intraocular haemorrhage (vitreous, choroidal, or retinal) with warfarin and new oral anticoagulants (NOACs) (including dabigatran, rivaroxaban, apixaban) from the...NICE drugs: an update on what’s good to go
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...Post-Brexit deal welcomed but leaves future relationship with EU far from settled
Rod McNeil breaks down the impact of the Brexit deal on healthcare in the UK, including medicines regulation, research funding, sharing of information and the ability to work abroad. A disorderly no-deal exit from the European Union (EU) was averted...RCOphth Annual Congress - Day 3
Follow live updates and key highlights from Day 3 of the RCOphth Annual Congress.
The Eye in History
Amongst the numerous texts that are available, one occasionally encounters a history of ophthalmology. There is such rapid development of technology in recent years and one can get drawn into the minutiae of a particular subject, losing track of the...
